CIK 704562

Avid Bioservices, Inc.

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

33%

HALO · FY to 2024-04-30

Named-customer revenue

$46.2M

1 customer · FY to 2024-04-30

Latest period

Apr 30, 2024

10-K filed 2024-07-02

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies Avid Bioservices, Inc. discloses as major customers, as a share of Avid Bioservices, Inc. revenue. 1 active, 0 lapsed.

Company	% of Avid Bioservices, Inc. revenue	Est. revenue	Period	Trend	Status	Source
HALO HALOZYME THERAPEUTICS, INC.	33%	$46.2M	FY 2024-04-30	−20.0pp	Active	10-K 2024-07-02
Halozyme Therapeutics, Inc. (1) U.S. 33 % 53 % 41 % 10-K filed 2024-07-02 Period FY 2023-05-01 to 2024-04-30 (33%), FY 2022-05-01 to 2023-04-30 (53%), FY 2021-05-01 to 2022-04-30 (41%)Accession 0001683168-24-004610 Halozyme Therapeutics, Inc. (1) U.S. 53 % 41 % 51 % 10-K/A filed 2024-04-24 Period FY 2020-05-01 to 2021-04-30 (51%)Accession 0001683168-24-002656 Halozyme Therapeutics, Inc. (1) U.S. 41 % 51 % 28 % 10-K filed 2022-06-29 Period FY 2019-05-01 to 2020-04-30 (28%)Accession 0001683168-22-004704

Unnamed major customers

Disclosed without names in the fiscal year ending 2024-04-30. Identities are not inferred.

Customer97%

Alerts are coming

Get an email when Avid Bioservices, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.